Search Results

Simulations Plus, Inc. today announced that, through a joint proposal with the University of Bath’s Department of Life Sciences and other university partners, it has been awarded a new funded grant from the U.S. Food and Drug Administration (FDA).

Cumulus Neuroscience (Cumulus; The Company) today announced a major research collaboration with the Universities of Bath and Bristol on development of the Fastball electroencephalogram (EEG) test, an innovative diagnostic test for earlier detection of Alzheimer’s Dementia (AD).

Simulations Plus, Inc today announced that, through a joint proposal with the University of Bath’s Department of Life Sciences, it has been awarded a new funded grant from the U.S. Food and Drug Administration.

Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.

Sapience Therapeutics , Inc., a clinical stage biotechnology company focused on discovering and developing peptide therapeutics to address difficult to treat oncology indications, announced today that it has renewed its research collaboration agreement with the University of Bath for the discovery of new therapeutic agents. “The continuation of this drug discovery partnership with Dr. Jody Mason and the University of Bath speaks to the succ

Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.

In this episode of Denatured BioSpace’s head of insights Lori Ellis discusses the public health consequences of vaccine hesitancy and the critical distinction between skepticism and cynicism with Paul Offit, MD, director of the Vaccine Education Center at the Children’s Hospital of Philadelphia.